BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21499773)

  • 1. Wilms tumor--a renal stem cell malignancy?
    Pode-Shakked N; Dekel B
    Pediatr Nephrol; 2011 Sep; 26(9):1535-43. PubMed ID: 21499773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental tumourigenesis: NCAM as a putative marker for the malignant renal stem/progenitor cell population.
    Pode-Shakked N; Metsuyanim S; Rom-Gross E; Mor Y; Fridman E; Goldstein I; Amariglio N; Rechavi G; Keshet G; Dekel B
    J Cell Mol Med; 2009 Aug; 13(8B):1792-1808. PubMed ID: 20187302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets.
    Pode-Shakked N; Shukrun R; Mark-Danieli M; Tsvetkov P; Bahar S; Pri-Chen S; Goldstein RS; Rom-Gross E; Mor Y; Fridman E; Meir K; Simon A; Magister M; Kaminski N; Goldmacher VS; Harari-Steinberg O; Dekel B
    EMBO Mol Med; 2013 Jan; 5(1):18-37. PubMed ID: 23239665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Origins of DNA methylation defects in Wilms tumors.
    Anvar Z; Acurzio B; Roma J; Cerrato F; Verde G
    Cancer Lett; 2019 Aug; 457():119-128. PubMed ID: 31103718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilms' tumor blastemal stem cells dedifferentiate to propagate the tumor bulk.
    Shukrun R; Pode-Shakked N; Pleniceanu O; Omer D; Vax E; Peer E; Pri-Chen S; Jacob J; Hu Q; Harari-Steinberg O; Huff V; Dekel B
    Stem Cell Reports; 2014 Jul; 3(1):24-33. PubMed ID: 25068119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CITED1 confers stemness to Wilms tumor and enhances tumorigenic responses when enriched in the nucleus.
    Murphy AJ; Pierce J; de Caestecker C; Ayers GD; Zhao A; Krebs JR; Saito-Diaz VK; Lee E; Perantoni AO; de Caestecker MP; Lovvorn HN
    Oncotarget; 2014 Jan; 5(2):386-402. PubMed ID: 24481423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Characterization of the Wilms Tumor Cancer Stem Cell.
    Petrosyan A; Villani V; Aguiari P; Thornton ME; Wang Y; Rajewski A; Zhou S; Cravedi P; Grubbs BH; De Filippo RE; Sedrakyan S; Lemley KV; Csete M; Da Sacco S; Perin L
    Adv Sci (Weinh); 2023 Jul; 10(20):e2206787. PubMed ID: 37114795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The yin and yang of kidney development and Wilms' tumors.
    Hohenstein P; Pritchard-Jones K; Charlton J
    Genes Dev; 2015 Mar; 29(5):467-82. PubMed ID: 25737276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms' tumor.
    Murphy AJ; Pierce J; de Caestecker C; Taylor C; Anderson JR; Perantoni AO; de Caestecker MP; Lovvorn HN
    J Pediatr Surg; 2012 Jun; 47(6):1239-49. PubMed ID: 22703800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
    Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
    Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Catenin and K-RAS synergize to form primitive renal epithelial tumors with features of epithelial Wilms' tumors.
    Clark PE; Polosukhina D; Love H; Correa H; Coffin C; Perlman EJ; de Caestecker M; Moses HL; Zent R
    Am J Pathol; 2011 Dec; 179(6):3045-55. PubMed ID: 21983638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study.
    Gadd S; Huff V; Huang CC; Ruteshouser EC; Dome JS; Grundy PE; Breslow N; Jennings L; Green DM; Beckwith JB; Perlman EJ
    Neoplasia; 2012 Aug; 14(8):742-56. PubMed ID: 22952427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney.
    Dekel B; Metsuyanim S; Schmidt-Ott KM; Fridman E; Jacob-Hirsch J; Simon A; Pinthus J; Mor Y; Barasch J; Amariglio N; Reisner Y; Kaminski N; Rechavi G
    Cancer Res; 2006 Jun; 66(12):6040-9. PubMed ID: 16778176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant activation, nuclear localization, and phosphorylation of Yes-associated protein-1 in the embryonic kidney and Wilms tumor.
    Murphy AJ; Pierce J; de Caestecker C; Libes J; Neblett D; de Caestecker M; Perantoni AO; Tanigawa S; Anderson JR; Dome JS; Das A; Carroll TJ; Lovvorn HN
    Pediatr Blood Cancer; 2014 Feb; 61(2):198-205. PubMed ID: 24115727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features.
    Takahashi M; Yang XJ; Lavery TT; Furge KA; Williams BO; Tretiakova M; Montag A; Vogelzang NJ; Re GG; Garvin AJ; Söderhäll S; Kagawa S; Hazel-Martin D; Nordenskjold A; Teh BT
    Cancer Res; 2002 Nov; 62(22):6598-605. PubMed ID: 12438255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hepatocyte growth factor and its receptor met in Wilms' tumors and nephrogenic rests reflects their roles in kidney development.
    Vuononvirta R; Sebire NJ; Messahel B; Perusinghe N; Reis-Filho JS; Pritchard-Jones K; Vujanic GM; Jones C
    Clin Cancer Res; 2009 Apr; 15(8):2723-30. PubMed ID: 19318497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor suppressor WT1 drives progenitor cell progression and epithelialization to prevent Wilms tumorigenesis in human kidney organoids.
    Waehle V; Ungricht R; Hoppe PS; Betschinger J
    Stem Cell Reports; 2021 Sep; 16(9):2107-2117. PubMed ID: 34450039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-483-5p Targets MKNK1 to Suppress Wilms' Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo.
    Liu K; He B; Xu J; Li Y; Guo C; Cai Q; Wang S
    Med Sci Monit; 2019 Feb; 25():1459-1468. PubMed ID: 30798328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephron Progenitor But Not Stromal Progenitor Cells Give Rise to Wilms Tumors in Mouse Models with β-Catenin Activation or Wt1 Ablation and Igf2 Upregulation.
    Huang L; Mokkapati S; Hu Q; Ruteshouser EC; Hicks MJ; Huff V
    Neoplasia; 2016 Feb; 18(2):71-81. PubMed ID: 26936393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wilms tumor chromatin profiles highlight stem cell properties and a renal developmental network.
    Aiden AP; Rivera MN; Rheinbay E; Ku M; Coffman EJ; Truong TT; Vargas SO; Lander ES; Haber DA; Bernstein BE
    Cell Stem Cell; 2010 Jun; 6(6):591-602. PubMed ID: 20569696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.